The 68Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma)

Stephane Chauvie; Fabrizio Bergesio; Federica Fioroni; Marco Brambilla; Alberto Biggi; Annibale Versari; Luca Guerra; Giovanni Storto; Pellegrino Musto; Stefano Luminari; Maria G. Cabras; Monica Balzarotti; Luigi Rigacci; Maurizio Martelli; Umberto Vitolo; Massimo Federico; Andrea Gallamini

doi:10.1016/j.ejmp.2016.04.004

The ⁶⁸Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma)

Stephane Chauvie, Fabrizio Bergesio, Federica Fioroni, Marco Brambilla, Alberto Biggi, Annibale Versari, Luca Guerra, Giovanni Storto, Pellegrino Musto, Stefano Luminari, Maria G. Cabras, Monica Balzarotti, Luigi Rigacci, Maurizio Martelli, Umberto Vitolo, Massimo Federico, Andrea Gallamini

Research output: Contribution to journal › Article

Abstract

Purpose: The quantitative assessment of Positron Emission Tomography (PET) scans using standardized uptake value and derived parameters proved to be superior to traditional qualitative assessment in several retrospective or mono-centric prospective reports. Since different scanners give different quantitative readings, a program for clinical trial qualification (CTQ) is mandatory to guarantee a reliable and reproducible use of quantitative PET in prospective multi-centre clinical trials and in every-day clinical life. Methods: We set up, under the auspices of Italian Foundation on Lymphoma (FIL), a CTQ program consisting of the PET/CT scan acquisition and analysis of ¹⁸F and ⁶⁸Ge NEMA/IEC image quality phantoms for the reduction of inter-scanner variability. Variability was estimated on background activity concentration (BAC) and sphere to background ratio (SBR). Results: The use of a ⁶⁸Ge phantom allowed reducing the inter-scanner variability among different scanners from 74.0% to 20.5% in BAC and from 63.3% to 17.4% in SBR compared to using the ¹⁸F phantom. The CTQ criteria were fulfilled at first round in 100% and 28% of PET scanners with ⁶⁸Ge and ¹⁸F respectively. Conclusions: The ⁶⁸Ge phantom proved a reliable tool for PET scanner qualification, able to significantly reduce the potential sources of error while increasing the reproducibility of PET derived quantitative parameter measurement.

Original language	English
Pages (from-to)	651-6
Number of pages	6
Journal	Physica Medica
Volume	32
Issue number	5
DOIs	https://doi.org/10.1016/j.ejmp.2016.04.004
Publication status	Published - May 1 2016

Fingerprint

Keywords

Clinical trials
Lymphoma
Positron emission tomography
Quantitative imaging

ASJC Scopus subject areas

Biophysics
Radiology Nuclear Medicine and imaging
Physics and Astronomy(all)

Cite this

Chauvie, S., Bergesio, F., Fioroni, F., Brambilla, M., Biggi, A., Versari, A., Guerra, L., Storto, G., Musto, P., Luminari, S., Cabras, M. G., Balzarotti, M., Rigacci, L., Martelli, M., Vitolo, U., Federico, M., & Gallamini, A. (2016). The ⁶⁸Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma). Physica Medica, 32(5), 651-6. https://doi.org/10.1016/j.ejmp.2016.04.004

The ⁶⁸Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma). / Chauvie, Stephane; Bergesio, Fabrizio; Fioroni, Federica; Brambilla, Marco; Biggi, Alberto; Versari, Annibale; Guerra, Luca; Storto, Giovanni; Musto, Pellegrino; Luminari, Stefano; Cabras, Maria G.; Balzarotti, Monica; Rigacci, Luigi; Martelli, Maurizio; Vitolo, Umberto; Federico, Massimo; Gallamini, Andrea.

In: Physica Medica, Vol. 32, No. 5, 01.05.2016, p. 651-6.

Research output: Contribution to journal › Article

Chauvie, S, Bergesio, F, Fioroni, F, Brambilla, M, Biggi, A, Versari, A, Guerra, L, Storto, G, Musto, P, Luminari, S, Cabras, MG, Balzarotti, M, Rigacci, L, Martelli, M, Vitolo, U, Federico, M & Gallamini, A 2016, 'The ⁶⁸Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma)', Physica Medica, vol. 32, no. 5, pp. 651-6. https://doi.org/10.1016/j.ejmp.2016.04.004

Chauvie, Stephane ; Bergesio, Fabrizio ; Fioroni, Federica ; Brambilla, Marco ; Biggi, Alberto ; Versari, Annibale ; Guerra, Luca ; Storto, Giovanni ; Musto, Pellegrino ; Luminari, Stefano ; Cabras, Maria G. ; Balzarotti, Monica ; Rigacci, Luigi ; Martelli, Maurizio ; Vitolo, Umberto ; Federico, Massimo ; Gallamini, Andrea. / The ⁶⁸Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma). In: Physica Medica. 2016 ; Vol. 32, No. 5. pp. 651-6.

@article{fff484485dc04c819f2aa06530ee1363,

title = "The 68Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma)",

abstract = "Purpose: The quantitative assessment of Positron Emission Tomography (PET) scans using standardized uptake value and derived parameters proved to be superior to traditional qualitative assessment in several retrospective or mono-centric prospective reports. Since different scanners give different quantitative readings, a program for clinical trial qualification (CTQ) is mandatory to guarantee a reliable and reproducible use of quantitative PET in prospective multi-centre clinical trials and in every-day clinical life. Methods: We set up, under the auspices of Italian Foundation on Lymphoma (FIL), a CTQ program consisting of the PET/CT scan acquisition and analysis of 18F and 68Ge NEMA/IEC image quality phantoms for the reduction of inter-scanner variability. Variability was estimated on background activity concentration (BAC) and sphere to background ratio (SBR). Results: The use of a 68Ge phantom allowed reducing the inter-scanner variability among different scanners from 74.0% to 20.5% in BAC and from 63.3% to 17.4% in SBR compared to using the 18F phantom. The CTQ criteria were fulfilled at first round in 100% and 28% of PET scanners with 68Ge and 18F respectively. Conclusions: The 68Ge phantom proved a reliable tool for PET scanner qualification, able to significantly reduce the potential sources of error while increasing the reproducibility of PET derived quantitative parameter measurement.",

keywords = "Clinical trials, Lymphoma, Positron emission tomography, Quantitative imaging",

author = "Stephane Chauvie and Fabrizio Bergesio and Federica Fioroni and Marco Brambilla and Alberto Biggi and Annibale Versari and Luca Guerra and Giovanni Storto and Pellegrino Musto and Stefano Luminari and Cabras, {Maria G.} and Monica Balzarotti and Luigi Rigacci and Maurizio Martelli and Umberto Vitolo and Massimo Federico and Andrea Gallamini",

year = "2016",

month = may

day = "1",

doi = "10.1016/j.ejmp.2016.04.004",

language = "English",

volume = "32",

pages = "651--6",

journal = "Physica Medica",

issn = "1120-1797",

publisher = "Associazione Italiana di Fisica Medica",

number = "5",

}

TY - JOUR

T1 - The 68Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma)

AU - Chauvie, Stephane

AU - Bergesio, Fabrizio

AU - Fioroni, Federica

AU - Brambilla, Marco

AU - Biggi, Alberto

AU - Versari, Annibale

AU - Guerra, Luca

AU - Storto, Giovanni

AU - Musto, Pellegrino

AU - Luminari, Stefano

AU - Cabras, Maria G.

AU - Balzarotti, Monica

AU - Rigacci, Luigi

AU - Martelli, Maurizio

AU - Vitolo, Umberto

AU - Federico, Massimo

AU - Gallamini, Andrea

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Purpose: The quantitative assessment of Positron Emission Tomography (PET) scans using standardized uptake value and derived parameters proved to be superior to traditional qualitative assessment in several retrospective or mono-centric prospective reports. Since different scanners give different quantitative readings, a program for clinical trial qualification (CTQ) is mandatory to guarantee a reliable and reproducible use of quantitative PET in prospective multi-centre clinical trials and in every-day clinical life. Methods: We set up, under the auspices of Italian Foundation on Lymphoma (FIL), a CTQ program consisting of the PET/CT scan acquisition and analysis of 18F and 68Ge NEMA/IEC image quality phantoms for the reduction of inter-scanner variability. Variability was estimated on background activity concentration (BAC) and sphere to background ratio (SBR). Results: The use of a 68Ge phantom allowed reducing the inter-scanner variability among different scanners from 74.0% to 20.5% in BAC and from 63.3% to 17.4% in SBR compared to using the 18F phantom. The CTQ criteria were fulfilled at first round in 100% and 28% of PET scanners with 68Ge and 18F respectively. Conclusions: The 68Ge phantom proved a reliable tool for PET scanner qualification, able to significantly reduce the potential sources of error while increasing the reproducibility of PET derived quantitative parameter measurement.

AB - Purpose: The quantitative assessment of Positron Emission Tomography (PET) scans using standardized uptake value and derived parameters proved to be superior to traditional qualitative assessment in several retrospective or mono-centric prospective reports. Since different scanners give different quantitative readings, a program for clinical trial qualification (CTQ) is mandatory to guarantee a reliable and reproducible use of quantitative PET in prospective multi-centre clinical trials and in every-day clinical life. Methods: We set up, under the auspices of Italian Foundation on Lymphoma (FIL), a CTQ program consisting of the PET/CT scan acquisition and analysis of 18F and 68Ge NEMA/IEC image quality phantoms for the reduction of inter-scanner variability. Variability was estimated on background activity concentration (BAC) and sphere to background ratio (SBR). Results: The use of a 68Ge phantom allowed reducing the inter-scanner variability among different scanners from 74.0% to 20.5% in BAC and from 63.3% to 17.4% in SBR compared to using the 18F phantom. The CTQ criteria were fulfilled at first round in 100% and 28% of PET scanners with 68Ge and 18F respectively. Conclusions: The 68Ge phantom proved a reliable tool for PET scanner qualification, able to significantly reduce the potential sources of error while increasing the reproducibility of PET derived quantitative parameter measurement.

KW - Clinical trials

KW - Lymphoma

KW - Positron emission tomography

KW - Quantitative imaging

UR - http://www.scopus.com/inward/record.url?scp=84964579687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964579687&partnerID=8YFLogxK

U2 - 10.1016/j.ejmp.2016.04.004

DO - 10.1016/j.ejmp.2016.04.004

M3 - Article

AN - SCOPUS:84964579687

VL - 32

SP - 651

EP - 656

JO - Physica Medica

JF - Physica Medica

SN - 1120-1797

IS - 5

ER -

Access to Document

10.1016/j.ejmp.2016.04.004